CytoSorb® Hemoadsorption as a Promising Tool to Handle COVID-19-Induced Cytokine Storm
Accumulating evidence suggests that a patient subgroup with severe COVID-19 develops a cytokine release syndrome leading to capillary leakage and organ injury. Recent publications addressing therapy of cytokine storms recommended new extracorporeal therapies such as hemoadsorption. This case report...
Saved in:
Main Authors: | Alice-Christin Acevedo, Michael Zoller, Christina Scharf, Uwe Liebchen, Michael Irlbeck, Ines Schroeder |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-01-01
|
Series: | Case Reports in Critical Care |
Online Access: | http://dx.doi.org/10.1155/2021/9937499 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CytoSorb hemoadsorption of apixaban during cardio-pulmonary bypass for heart transplantation
by: Anouk Frering, MD, et al.
Published: (2025-02-01) -
Cardiogenic Shock in a Hemodialyzed Patient on Flecainide: Treatment with Intravenous Fat Emulsion, Extracorporeal Cardiac Life Support, and CytoSorb® Hemoadsorption
by: Nicolas De Schryver, et al.
Published: (2019-01-01) -
To Hemoadsorb or Not to Hemoadsorb—Do We Have the Answer Yet? An Updated Meta-Analysis on the Use of CytoSorb in Sepsis and Septic Shock
by: Carmen Orban, et al.
Published: (2025-01-01) -
Hemoadsorption in Multiorgan Failure Due to Viscerocutaneous Loxoscelism
by: Raúl Valenzuela Córdova, et al.
Published: (2025-01-01) -
Effect of Hemoadsorption for Cytokine Removal in Pneumococcal and Meningococcal Sepsis
by: Francesca Leonardis, et al.
Published: (2018-01-01)